Suspected fungal infection
Supports provider evaluation and treatment planning when clinically appropriate.
Comprehensive Fungal Panel
The Comprehensive Fungal PCR Panel supports molecular detection of clinically relevant fungal organisms, helping providers evaluate suspected fungal infections with greater diagnostic clarity.
Overview
Provider-facing PCR testing support for clinically meaningful molecular diagnostic information.
This PCR panel is designed to support evaluation of suspected fungal infection when molecular detection may provide useful diagnostic information.
The panel can assist providers in cases where traditional identification may be slow, inconclusive, or insufficient for care planning.
Results are intended to support provider interpretation alongside the patient's presentation, specimen source, and other clinical information.
Clinical Use
Supports provider evaluation and treatment planning when clinically appropriate.
Supports provider evaluation and treatment planning when clinically appropriate.
Supports provider evaluation and treatment planning when clinically appropriate.
Supports provider evaluation and treatment planning when clinically appropriate.
Supports provider evaluation and treatment planning when clinically appropriate.
Supports provider evaluation and treatment planning when clinically appropriate.
Molecular Testing Advantage
PCR technology can support detection of fungal organisms through molecular targets, helping providers obtain clinically useful information in cases where fungal identification is important to treatment planning.
Molecular testing can help providers receive clinically useful information for interpretation alongside the full clinical picture.
Molecular testing can help providers receive clinically useful information for interpretation alongside the full clinical picture.
Molecular testing can help providers receive clinically useful information for interpretation alongside the full clinical picture.
Provider Workflow
Providers collect and submit specimens according to the final Ipsum Diagnostics ordering and collection instructions.
The laboratory performs PCR-based molecular testing designed to detect relevant molecular targets for the submitted panel.
Results are reported to support provider interpretation and timely clinical decision-making when clinically appropriate.
Ipsum Diagnostics can support onboarding, ordering questions, specimen guidance, and follow-up needs.
Partner With Ipsum Diagnostics
Contact Ipsum Diagnostics to learn more about this PCR testing panel, provider onboarding, specimen requirements, and ordering support.